Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$546M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$362M |
| 4 |
Meta Platforms (Facebook)
META
|
+$350M |
| 5 |
Coca-Cola
KO
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$1.04B |
| 2 |
Palantir
PLTR
|
+$800M |
| 3 |
Apple
AAPL
|
+$516M |
| 4 |
Netflix
NFLX
|
+$326M |
| 5 |
NVIDIA
NVDA
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.71% |
| 2 | Healthcare | 15.15% |
| 3 | Consumer Discretionary | 11.78% |
| 4 | Communication Services | 10.55% |
| 5 | Financials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TRIB
3151
Trinity Biotech
TRIB
$5.57M
| $178K | ﹤0.01% |
5,712
+3,813
| +201% | +$120K |
2013 Q2
49 quarters
|
|
3152
UTStarcom
UTSI
$21.5M
| $178K | ﹤0.01% |
70,088
-6,300
| -8% | -$15.6K |
2013 Q2
49 quarters
|
|
3153
Cohen & Co
COHN
$34.4M
| $177K | ﹤0.01% |
15,800
+200
| +1% | +$2.29K |
2024 Q2
5 quarters
|
|
3154
Kartoon Studios
TOON
$33.9M
| $175K | ﹤0.01% |
+237,549
| New | +$178K |
2025 Q3
0 quarters
|
|
3155
Oric Pharmaceuticals
ORIC
$1.24B
| $174K | ﹤0.01% |
14,500
+4,300
| +42% | +$45.2K |
2025 Q2
1 quarter
|
|
|
SMCL
3156
GraniteShares 2x Long SMCI Daily ETF
SMCL
$48.2M
| $174K | ﹤0.01% |
+1,785
| New | +$191K |
2025 Q3
0 quarters
|
|
|
YQ
3157
17 Education & Technology Group
YQ
$32.8M
| $174K | ﹤0.01% |
40,581
+3,751
| +10% | +$9.17K |
2021 Q3
16 quarters
|
|
|
PAAI
3158
Paradium.AI, Inc.
PAAI
$51.4M
| $173K | ﹤0.01% |
31,700
+15,100
| +91% | +$94K |
2024 Q4
3 quarters
|
|
3159
Xilio Therapeutics
XLO
$59.6M
| $173K | ﹤0.01% |
14,621
+2,892
| +25% | +$29K |
2022 Q2
13 quarters
|
|
3160
Sono-Tek
SOTK
$111M
| $171K | ﹤0.01% |
38,700
+7,700
| +25% | +$27.9K |
2023 Q4
7 quarters
|
|
3161
Harte-Hanks
HHS
$33.2M
| $171K | ﹤0.01% |
46,000
+7,200
| +19% | +$26K |
2022 Q1
14 quarters
|
|
3162
Fathom Holdings
FTHM
$7.27M
| $171K | ﹤0.01% |
94,800
-14,700
| -13% | -$24.5K |
2022 Q2
13 quarters
|
|
3163
GEE Group
JOB
$23.6M
| $170K | ﹤0.01% |
824,741
+63,200
| +8% | +$12.8K |
2022 Q1
14 quarters
|
|
3164
Entera Bio
ENTX
$462M
| $170K | ﹤0.01% |
88,400
+24,100
| +37% | +$46.1K |
2022 Q3
12 quarters
|
|
|
SGRP
3165
DELISTED
SPAR Group
SGRP
| $169K | ﹤0.01% |
163,900
-37,400
| -19% | -$41.5K |
2020 Q4
19 quarters
|
|
3166
Roma Green Finance Ltd
ROMA
$521M
| $168K | ﹤0.01% |
+57,600
| New | +$176K |
2025 Q3
0 quarters
|
|
3167
Motorsport Games
MSGM
$23.5M
| $167K | ﹤0.01% |
59,600
+30,400
| +104% | +$93.7K |
2025 Q2
1 quarter
|
|
|
NSTS
3168
DELISTED
NSTS Bancorp
NSTS
| $166K | ﹤0.01% |
14,400
| – | – |
2024 Q4
3 quarters
|
|
3169
NextCure
NXTC
$32.9M
| $166K | ﹤0.01% |
28,334
-13,411
| -32% | -$70.2K |
2021 Q2
17 quarters
|
|
|
FDSB
3170
Fifth District Bancorp
FDSB
$90.7M
| $166K | ﹤0.01% |
+12,000
| New | +$161K |
2025 Q3
0 quarters
|
|
|
CARV
3171
DELISTED
Carver Bancorp
CARV
| $165K | ﹤0.01% |
68,600
+18,300
| +36% | +$38.7K |
2022 Q1
14 quarters
|
|
3172
Enlivex Ltd
ENLV
$5.06M
| $164K | ﹤0.01% |
10,486
-740
| -7% | -$13.3K |
2016 Q2
37 quarters
|
|
|
TOUR
3173
Tuniu
TOUR
$53.8M
| $164K | ﹤0.01% |
17,173
-20
| -0.1% | -$172 |
2017 Q1
34 quarters
|
|
3174
Cue Biopharma
CUE
$201M
| $163K | ﹤0.01% |
7,569
+3,120
| +70% | +$73.2K |
2025 Q1
2 quarters
|
|
3175
SAB Biotherapeutics
SABS
$271M
| $162K | ﹤0.01% |
80,840
+69,810
| +633% | +$158K |
2025 Q1
2 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2025 Portfolio in Review
As of Q3 2025, Renaissance Technologies held 4,038 positions worth $75.8B, up 0.77% from $75.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $5.41B in Q3 2025, closing 581 positions and reducing 1,457 holdings. Its most notable exit was GE Aerospace, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Alphabet (Google) Class C worth $419M.
- Renaissance Technologies's largest Q3 2025 buy was Alphabet (Google) Class C: 1,720,002 shares worth $419M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2025, an estimated $546M increase.
- Renaissance Technologies's biggest Q3 2025 reduction was Robinhood, cutting an estimated $1.04B.
- Renaissance Technologies fully exited GE Aerospace in Q3 2025, selling an estimated $235M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.8B portfolio in Q3 2025.
- Renaissance Technologies opened 515 new positions and closed 581 in Q3 2025.
- Renaissance Technologies's portfolio value rose 0.77% quarter-over-quarter to $75.8B.
Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.